Digital Health Global

MARCH 2, 2023

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Digital Health Global

MARCH 16, 2023

The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the life sciences. Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space.

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Lloyd Price

FEBRUARY 18, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals 64

Pharmaceuticals healthcare technology Digital Health Remote care 64

Healthcare IT Today

JANUARY 23, 2024

By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drug development. QuantHealth is already working with several global pharmaceutical companies to use its product in clinical trial design and development. Petra Jantzer, Ph.D., Originally announced January 8th, 2024

Drug Development 93

Drug Development Pharmaceuticals Life Science BioTech 93

Healthcare IT Today

JANUARY 17, 2024

and Director of Clinical Strategy at Particle Health I believe a huge place where generative AI will be able to gain traction in healthcare in 2024 is in developing operational workflows and clinical pathways for resource allocation to specific patient cohorts. Carolyn Ward, M.D.

Health IT 109

Health IT Mental health Interoperability Patient Experience 109